In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
|Articles|April 6, 2015
Full Field Digital Mammography May Miss Interval Breast Cancers
Author(s)Diagnostic Imaging Staff
Full field digital mammography, performed instead of screen film mammography, finds fewer interval breast cancers.
Advertisement
The switch to full field digital mammography (FFDM) has changed the mammographic presentation of interval breast cancer, with fewer interval cancers presenting in association with microcalcifications, according to a study published in the
Researchers from Ireland sought to assess the impact of FFDM on the classification of interval breast cancers and to compare the mammographic features of interval cancers at FFDM and screen film mammography (SFM).
The researchers looked at 76 cases of interval breast cancer following FFDM screening and 62 following SFM screening. Five consultant breast radiologists assessed prior screening mammograms. The review classified cases as missed, minimal signs, occult, or true interval breast cancer. Mammographic features of the interval cancer at diagnosis and any abnormality identified on the prior screening mammogram were recorded.
The results showed that there was not much difference between FFDM and SFM for missed cancers, but there were significantly fewer interval cancers presenting as microcalcifications following SFM.
FFDM
SFM
Missed cancers
10.5% (8 of 76)
8.1% (5 of 62)
Interval cancers
16% (12 of 76)
32% (20 of 62)
The interval breast cancers did not show up as frequently with FFDM, so this can be problematic, concluded the researchers.
Advertisement
Related to this article
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
Catch up on the top radiology content of the past week.
In the latest episode of her “Breast Imaging in Focus” series, Manisha Bahl, MD, MPH, FSBI, offer pertinent takeaways for breast radiologists from recently issued guidelines for addressing proliferative breast lesions with atypia and lobular carcinoma in situ (LCIS).
Catch up on the top radiology content of the past week.
In a recent interview, Stamatia Destounis, MD, FACR, shared her perspective on recent changes to the BI-RADS system, offering insights on contrast-enhanced mammography, reporting changes for breast MRI and ultrasound, and the importance of auditing for BI-RADS category 3 assessments.
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
2
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
3
Current Perspectives on Integrating AI into Radiology
4
Raising Questions on the Prognostic Value of Fractional Flow Reserve from CCTA
5